BioSpace News Archive

BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, announced that Robert Paccasassi has been appointed Vice President of Quality Assurance/Regulatory Compliance.

Sotera Health Company today is providing an update on the Company’s accomplishments and key growth drivers, as well as the current market dynamics related to its businesses.

LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced its C-reactive protein (CRP) Test has achieved CE Marking.

Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today presents long-term safety and efficacy data from the open-label extension (OLE) of its global Phase 3 MPOWERED non-inferiority clinical trial that compared Mycapssa® (oral octreotide capsules) to long-acting iSRLs for maintenance of biochemical response in patients with acromegaly.

Black Diamond Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for its MasterKey inhibitor BDTX-1535.

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced that its Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test is now available in the Optum Store.

CareDx, Inc. today announced recent drug development collaborations with three leading cell therapy biopharmaceutical companies to use CareDx’s AlloCell™ surveillance in the respective companies’ ongoing CAR T-cell therapy clinical studies.

ASLAN Pharmaceuticals announced that the results from the dose escalation portion of the completed Phase 1b Proof-of-Concept study of ASLAN004 in atopic dermatitis have been accepted for poster presentation at the 2022 Winter Clinical Dermatology Conference, to be held in Koloa, Hawaii, January 14-19, 2022.

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) is providing a letter to shareholders.

Akumin Inc. is pleased to announce that Riadh Zine , Chairman & Co-CEO, and Rhonda Longmore-Grund , President & Co-CEO, will present virtually at the 40th Annual J.P. Morgan Health Care Conference on Wednesday, January 12, 2022, at 2:15pm EST .